Pure Foods Tasmania Limited (PFT) ORDINARY FULLY PAID |
Consumer Staple |
$5 |
Appointment of Executive Chair
|
28 Aug 2024 10:13AM |
$0.027 |
$0.035 |
risen by
29.63%
|
|
BCAL Diagnostics Limited (BDX) ORDINARY FULLY PAID |
Health Care |
$23 |
BCAL Commences US Operations
|
28 Aug 2024 10:10AM |
$0.130 |
$0.064 |
fallen by
50.77%
|
|
BDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Establishment of BCAL US subsidiary
- Dr. Klaus-Peter Adam joins BCAL as Director US Research and Product Development
- Lease of US premises secured and key equipment purchased
- BCAL US research laboratory to commence operations 2 September 2024
- Dr. Adam's appointment strengthens BCAL's global research team
- BCAL's US expansion funded by recent $10.5 million capital raising
- Collaboration with US Physicians at partner sites in Michigan and Chicago
- US operations crucial for BCAL's global market entry strategy
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
EDU Holdings Limited (EDU) ORDINARY FULLY PAID |
Consumer Discretionary |
$75 |
Trading Halt
|
28 Aug 2024 10:09AM |
$0.090 |
$0.500 |
risen by
455.56%
|
|
EDU - Price-sensitive ASX Announcement
Full Release
Key Points
- EDU Holdings Limited (ASX: EDU) requested a trading halt on 28 August 2024.
- The trading halt was requested pending an announcement related to the Government's proposed imposition of caps on new international student commencements in EDU’s operating businesses.
- The trading halt is expected to last until the earlier of the commencement of normal trading on Friday, 30 August 2024, or when the announcement is released.
- EDU Holdings Limited requests the trading halt to make an assessment of and announcement regarding the Government's proposal.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Qualitas Real Estate Income Fund (QRI) ORDINARY UNITS FULLY PAID |
Financials |
$996 |
Estimated Weekly NTA as at 26.08.2024
|
28 Aug 2024 10:07AM |
$1.625 |
$1.635 |
risen by
0.62%
|
|
Infomedia Limited (IFM) ORDINARY FULLY PAID |
Information Technology |
$641 |
Notification of cessation of securities - IFM
|
28 Aug 2024 10:07AM |
$1.770 |
$1.695 |
fallen by
4.24%
|
|
ENRG Elements Ltd (EEL) ORDINARY FULLY PAID |
Materials |
$5 |
Application for quotation of securities - EEL
|
28 Aug 2024 10:07AM |
$0.002 |
$0.002 |
fallen by
25%
|
|
WAM Strategic Value Limited (WAR) ORDINARY FULLY PAID |
Financials |
$204 |
Strong invest port perf, increased FF div and special FF div
|
28 Aug 2024 10:05AM |
$1.100 |
$1.135 |
risen by
3.18%
|
|
WAR - Price-sensitive ASX Announcement
Full Release
Key Points
- WAM Strategic Value Limited has shown strong investment portfolio performance.
- Increased fully franked dividends (FF div) have been declared.
- A special fully franked dividend (special FF div) has been announced.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
ENRG Elements Ltd (EEL) ORDINARY FULLY PAID |
Materials |
$5 |
COMPLETION OF ACQUISITION OF LAMONT LAKE URANIUM PROJECT
|
28 Aug 2024 10:05AM |
$0.002 |
$0.002 |
fallen by
25%
|
|
EEL - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of acquisition of the Lamont Lake uranium project in Saskatchewan, Canada.
- Total consideration for the acquisition was C$27,500 and 33,333,333 shares.
- A further payment of either A$100,000 in cash or shares will be made within 6 months.
- Share issuance for the deferred consideration is subject to shareholder approval.
- ENRG Elements aims to diversify jurisdictional risk and explore near-term potential.
- Caroline Keats, Managing Director, emphasizes the strategic value of the acquisition.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Advanced Health Intelligence Ltd (AHI) ORDINARY FULLY PAID |
Health Care |
$26 |
AHI Receives Additional Patent Protection in the EU
|
28 Aug 2024 10:01AM |
$0.092 |
$0.092 |
fallen by
0%
|
|
WAM Strategic Value Limited (WAR) ORDINARY FULLY PAID |
Financials |
$204 |
Appendix 4E and Annual Report
|
28 Aug 2024 10:01AM |
$1.100 |
$1.135 |
risen by
3.18%
|
|
WAR - Price-sensitive ASX Announcement
Full Release
Key Points
- WAM Strategic Value Limited has a focus on investing in discounted assets.
- The company achieved a net profit after tax of $28.7 million.
- WAM Strategic Value Limited's net tangible assets increased by 18.9% to $1.29 per share.
- A fully franked final dividend of 1.0 cent per share was declared.
- The company reported strong investment performance with a portfolio return of 18.6%.
- The total shareholder return for the year was 18.9%.
- The portfolio is valued based on observable market data.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Korvest Ltd (KOV) ORDINARY FULLY PAID |
Industrials |
$157 |
AGM date
|
28 Aug 2024 10:01AM |
$9.840 |
$13.250 |
risen by
34.65%
|
|
Sierra Rutile Holdings Limited (SRX) ORDINARY FULLY PAID |
Materials |
- |
Change in substantial holding
|
28 Aug 2024 10:00AM |
$0.175 |
$0.175 |
fallen by
0%
|
|
OpenLearning Limited (OLL) ORDINARY FULLY PAID |
Information Technology |
$7 |
Appendix 4D and Half Year Financial Report
|
28 Aug 2024 10:00AM |
$0.015 |
$0.014 |
fallen by
6.67%
|
|
OLL - Price-sensitive ASX Announcement
Full Release
Key Points
- Gross sales increased by 42.9% pcp to $1,931,184
- Revenue grew by 1.7% pcp to $1,070,194
- Loss after tax decreased by 25.4% pcp to $1,663,308
- Launch of generative AI tools including AI Course Builder and CourseMagic
- Adoption of AI tools by over 75% of customer base
- Acquisition of Australian higher education marketplaces rebranded as The Uni Guide
- Partnerships and expansion into Indian market with OpenLearning Bharat
- Annual recurring revenue (ARR) increased by 18% YoY to $2.17 million
- Operational efficiency and cost management led to reduced losses
- Active reseller agreements in Southeast Asia to promote platform
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Medical Developments International Limited (MVP) ORDINARY FULLY PAID |
Health Care |
$65 |
Application for quotation of securities - MVP
|
28 Aug 2024 9:59AM |
$0.470 |
$0.580 |
risen by
23.40%
|
|
SciDev Ltd (SDV) ORDINARY FULLY PAID |
Materials |
$63 |
Audited FY2024 Financial Statements and Appendix 4E
|
28 Aug 2024 9:59AM |
$0.480 |
$0.330 |
fallen by
31.25%
|
|
SDV - Price-sensitive ASX Announcement
Full Release
Key Points
- Record revenue of $109.2 million, up 22% from FY23.
- Underlying EBITDA increased to $8.8 million from $4.1 million in FY23.
- Net profit after tax increased to $2.2 million from $0.3 million in FY23.
- Significant growth in Water Technologies with 88% increase in revenue.
- Expansion into North American and European markets for PFAS treatment.
- Secured major contracts in Australia, including a $4.7 million PFAS treatment contract.
- Positive operating cash inflow of $6.5 million.
- Maintained a robust balance sheet with $9.4 million in cash and equivalents.
- Strategic initiatives leading to growth in mining, oil & gas, and water treatment sectors.
- No dividends declared during the financial year.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
AnteoTech Limited (ADO) ORDINARY FULLY PAID |
Materials |
$65 |
FY2024 Corporate Governance Statement and Appendix 45
|
28 Aug 2024 9:58AM |
$0.021 |
$0.024 |
risen by
14.29%
|
|
Excite Technology Services Limited (EXT) ORDINARY FULLY PAID |
Information Technology |
$19 |
Appendix 3Y - SB, NS
|
28 Aug 2024 9:58AM |
$0.010 |
$0.009 |
fallen by
10%
|
|
Blue Star Helium Limited (BNL) ORDINARY FULLY PAID |
Energy |
$24 |
Helium One Farms into Galactica / Pegasus Project
|
28 Aug 2024 9:57AM |
$0.005 |
$0.007 |
risen by
40%
|
|
BNL - Price-sensitive ASX Announcement
Full Release
Key Points
- Helium One to pay US$1.5 million to Blue Star on completion and fund the drilling of six development wells to earn a 50% interest in the Galactica / Pegasus project.
- Drilling of these initial six wells at Galactica (Phase 1 of the broader Galactica / Pegasus development) is expected during Q4 2024.
- Helium One has raised US$8.2 million in new equity.
- Blue Star remains Operator of the project.
- First helium (and CO2) production from Galactica / Pegasus expected during H1 2025.
- The Agreement with Helium One is subject to approval by the Colorado Energy and Carbon Management Commission (ECMC) and the execution of definitive governing agreements.
- Helium One’s obligation under the initial six well drilling programme is capped at US$0.45 million per well.
- The farm-out agreement includes mineral leases in respect of 61,151.99 gross acres (51,479.37 net acres) in the Galactica / Pegasus development.
- Blue Star drilled the first development well at Galactica in June 2024, which flowed 1.9% helium at 285 Mcfd in addition to 70% CO2.
- First production from the Phase 1 Galactica / Pegasus development is expected during H1 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Chimeric Therapeutics Limited (CHM) ORDINARY FULLY PAID |
Health Care |
$10 |
First patient dosed in Phase 1/2 trial of CHM CDH17
|
28 Aug 2024 9:57AM |
$0.016 |
$0.003 |
fallen by
81.25%
|
|
CHM - Price-sensitive ASX Announcement
Full Release
Key Points
- Chimeric Therapeutics Limited announced the first patient dosed in Phase 1/2 trial of CHM 1101 CDH17.
- The trial aims to evaluate the safety and efficacy of the CHM 1101 treatment.
- Initial dosing marks a significant milestone in the clinical development of CHM 1101.
- The company is focused on developing novel therapies for cancer treatment.
- The Phase 1/2 trial is a multi-center, open-label study.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Zeta Resources Limited (ZER) ORDINARY FULLY PAID |
Materials |
- |
Preliminary Final Report
|
28 Aug 2024 9:56AM |
$0.230 |
$0.220 |
fallen by
4.35%
|
|
ZER - Price-sensitive ASX Announcement
Full Release
Key Points
- Zeta Resources Limited reported a net loss after tax of US$33,069,153 for the year ended 30 June 2024.
- No dividends were declared or payable for the year ended 30 June 2024.
- Net tangible assets per share as at 30 June 2024 were US$0.20 (AU$0.30).
- The company’s investments are primarily in subsidiaries and listed equity securities, which saw significant fair value decreases.
- Total comprehensive loss for the year was US$33,069,153.
- The financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS) and the Bermuda Companies Act 1981.
- The company continued an on-market buy-back scheme and has repurchased and cancelled 32,210,125 fully paid ordinary shares.
- Net cash flows from investing activities amounted to US$22,681,859 for the year ended 30 June 2024.
- The company holds investments in subsidiaries including Kumarina Resources Pty Limited, Zeta Investments Limited, Zeta Energy Pte. Ltd., and Horizon Gold Limited.
- The financial report is based on accounts that are in the process of being audited.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Macro Metals Limited (M4M) ORDINARY FULLY PAID |
Materials |
$32 |
High-grade Hematite Outcrops at Goldsworthy East
|
28 Aug 2024 9:56AM |
$0.024 |
$0.008 |
fallen by
68.75%
|
|
M4M - Price-sensitive ASX Announcement
Full Release
Key Points
- Macro Metals Limited (M4M) reports high-grade hematite outcrops at Goldsworthy East.
- The outcrops show hematite mineralization with iron content up to 68%.
- Goldsworthy East is located in the Pilbara region of Western Australia.
- Further exploration and drilling are planned to assess the extent of the high-grade hematite.
- The company aims to develop a resource estimate and advance the project feasibility.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Kalina Power Limited (KPO) ORDINARY FULLY PAID |
Utilities |
$32 |
Reinstatement to quotation
|
28 Aug 2024 9:56AM |
$0.011 |
$0.011 |
fallen by
0%
|
|
KPO - Price-sensitive ASX Announcement
Full Release
Key Points
- Suspension of trading in Kalina Power Limited (KPO) securities will be lifted immediately.
- Reinstatement follows the announcement of a counterparty in a memorandum of understanding.
- Issued by ASX Compliance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Kalina Power Limited (KPO) ORDINARY FULLY PAID |
Utilities |
$32 |
Clarification Announcement
|
28 Aug 2024 9:56AM |
$0.011 |
$0.011 |
fallen by
0%
|
|
KPO - Price-sensitive ASX Announcement
Full Release
Key Points
- Kalina Power Limited made a clarification announcement on 28 August 2024
- The announcement provides further details on the execution of a non-binding Memorandum of Understanding (MOU) with Crusoe Energy Systems LLC
- The original announcement was made on 26 August 2024
- The MOU is related to a US-based data centre developer
- The announcement was approved and authorized for release by Ross MacLachlan, CEO
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
NICO Resources Limited (NC1) ORDINARY FULLY PAID |
Materials |
$12 |
Wingellina Resource Update
|
28 Aug 2024 9:56AM |
$0.130 |
$0.096 |
fallen by
26.15%
|
|
NC1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Nico Resources Limited announced the completion of an update to the Wingellina Mineral Resource Estimate (MRE)
- The 2024 Wingellina MRE is estimated at 187.3Mt at 0.91% Ni and 0.06% Co
- Modelling and gap analysis identified opportunities for resource increase with mineralisation open at depth and along strike
- The 2024 MRE closely corresponds with the previous 2016 Resource Estimate by MetalsX Limited
- Regolith modelling suggests Wingellina is an oxide dominant laterite deposit, supporting the use of HPAL technology
- Enhanced lithological and regolith boundary modelling from previous estimates
- Results from bench-scale metallurgical testwork will be incorporated into the updated model for geo-metallurgical development
- Wingellina hosts an initial reserve of 1.56 million tonnes of contained nickel
- The project is expected to produce approximately 40,000t of nickel and 3,000t of cobalt annually for at least 42 years
- The updated model will support optimized mine planning and material type definition
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Austal Limited (ASB) ORDINARY FULLY PAID |
Industrials |
$2,843 |
FY2024 Results - Conference Call Notice
|
28 Aug 2024 9:54AM |
$2.330 |
$6.750 |
risen by
189.70%
|
|